Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake.
about
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease modelsA New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects.Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance.Beta-Sitosterol: A Promising but Orphan Nutraceutical to Fight Against Cancer.Critical Analysis on Characterization, Systemic Effect, and Therapeutic Potential of Beta-Sitosterol: A Plant-Derived Orphan Phytosterol.A safe and efficient hepatocyte-selective carrier system based on myristoylated preS1/21-47 domain of hepatitis B virus.Hepatoprotective Effect of Silymarin (Silybum marianum) on Hepatotoxicity Induced by Acetaminophen in Spontaneously Hypertensive Rats.In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model.Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes.Silymarin-Loaded Nanoparticles Based on Stearic Acid-Modified Bletilla striata Polysaccharide for Hepatic Targeting.Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer CellsEnhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis
P2860
Q26775886-681424E4-3CDD-40F9-8FFE-6B4EB24C7702Q35870488-667FC8EC-448E-42AA-A5BF-32715EF63712Q38237705-3BB6F9BC-540B-4661-960C-0FF7A551BCA1Q38608961-BB3B78F4-DBE8-420D-A1EF-CFA9A3DD0734Q41747768-488789C8-AB2D-4597-BC90-A473841222E6Q41758629-3AD5101B-78EB-4ECF-9B21-89BCE8A30100Q41851695-8AAC3988-03F8-4464-8DA0-78E269580976Q48103883-983A7423-D56E-492D-A926-36BD4F1042C8Q48324641-B1AF79D5-B1EE-42A9-A39A-C510A82E1ECAQ51471983-84A5DECE-5A42-4F99-BF27-EFFAFF265E3FQ57826028-49E229EC-CD3F-49B6-828F-46266ED4EC4AQ58785915-50304780-BEDD-4ED5-8AC7-B037F88BFB2E
P2860
Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Silymarin loaded liposomes for ...... luation and HepG2 drug uptake.
@en
Silymarin loaded liposomes for ...... luation and HepG2 drug uptake.
@nl
type
label
Silymarin loaded liposomes for ...... luation and HepG2 drug uptake.
@en
Silymarin loaded liposomes for ...... luation and HepG2 drug uptake.
@nl
prefLabel
Silymarin loaded liposomes for ...... luation and HepG2 drug uptake.
@en
Silymarin loaded liposomes for ...... luation and HepG2 drug uptake.
@nl
P2093
P1476
Silymarin loaded liposomes for ...... luation and HepG2 drug uptake.
@en
P2093
Ahmed Samy
Alaa Kassem
Marjo Yliperttula
Mohammed Elmowafy
Sherif K Abu-Elyazid
P304
P356
10.1016/J.EJPS.2013.06.012
P407
P577
2013-07-12T00:00:00Z